UNIVERSITAETSKLINIKUM FREIBURG

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 25230
 
  
 
G01V GEOPHYSICS; GRAVITATIONAL MEASUREMENTS; DETECTING MASSES OR OBJECTS; TAGS 2159
 
  
 
C07K PEPTIDES 12124
 
  
 
G01R MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES 9150
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 7118
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 693
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 6200
 
  
 
A61B DIAGNOSIS; SURGERY; IDENTIFICATION 5235
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 392
 
  
 
C08B POLYSACCHARIDES; DERIVATIVES THEREOF 328

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0021,430 SELECTIVE TARGETING OF THE CD40L/MAC-1 INTERACTION BY SMALL PEPTIDE INHIBITORS AND ITS USE FOR THE TREATMENT OF INFLAMMATION AND ATHEROGENESISSep 20, 17Jan 25, 18[A61K, C07K]
2016/0354,439 BLOCKADE OF CCL18 SIGNALING VIA CCR6 AS A THERAPEUTIC OPTION IN FIBROTIC DISEASES AND CANCERMay 06, 16Dec 08, 16[A61K, C12N, C07K]
2015/0289,902 DEVICE FOR DETACHING PARIETAL THROMBI FROM A BLOOD VESSELOct 21, 13Oct 15, 15[A61B]
2013/0309,264 NOVEL ANTIGEN OF ENTEROCOCCAL PATHOGENS AND USE THEROF AS VACCINE COMPONENT FOR THERAPY AND/OR PROPHYLAXISNov 03, 11Nov 21, 13[C07K]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9808522 Selective targeting of the CD40L/Mac-1 interaction by small peptide inhibitors and its use for the treatment of inflammation and atherogenesisAug 17, 11Nov 07, 17[A61K, C07K]
9801832 Pharmaceutical composition having synergistic action of direct catalase inhibitors and modulators of no metabolism or of extracellular superoxide anion production which lead to catalase destructionJun 20, 13Oct 31, 17[A61K, C07K]
9795625 Uridine and uridine analogues for treatment of specific lung diseases, namely COPD and pulmonary fibrosisApr 12, 16Oct 24, 17[A61K, A01N]
9796744 antigenNov 13, 07Oct 24, 17[C07H, A61K, G01N, C08B]
9750796 and uses thereofMar 04, 13Sep 05, 17[A61K, C07H, C12P, C08B, C07K]
9695480 Method for the diagnosis of myeloid neoplasias and solid tumorsFeb 07, 13Jul 04, 17[C07H, C12Q]
9631235 Mitochondrial nucleic acid as a marker for autoimmune and autoinflammatory diseasesApr 30, 12Apr 25, 17[C12Q]
9494670 Method for improving robustness of 3D magnetic resonance imaging to involuntary motionOct 12, 13Nov 15, 16[G01R, G01V]
9476957 Method and apparatus for accelerating magnetic resonance imagingJul 23, 13Oct 25, 16[G01R]
9453052 Cyclotides as immunosuppressive agentsDec 21, 12Sep 27, 16[A61K, G01N, C07K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2016/0220,542 SYNERGISTIC ACTIVITY OF MODULATORS OF THE NO METABOLISM AND OF NADPH OXIDASE IN THE SENSITISATION OF TUMOR CELLSAbandonedFeb 04, 16Aug 04, 16[A61K]
2014/0377,324 Pharmaceutical Composition Comprising miRNA-100 And Its Use In The Modulation of Blood Vessel Growth and Endothelial InflammationAbandonedJun 30, 14Dec 25, 14[C12N]
2014/0218,690 METHOD AND DEVICE FOR ASCERTAINING AND MAPPING DATA REPRESENTING THE OPTICAL IMAGING PROPERTIES OF AN EYEAbandonedAug 17, 12Aug 07, 14[A61B]
2013/0280,821 METHOD FOR DETECTING AN INFECTION BY HEPATITIS B VIRUSAbandonedApr 18, 12Oct 24, 13[G01N]
2013/0171,104 SYNERGISTIC ACTIVITY OF MODULATORS OF THE NO METABOLISM AND OF NADPH OXIDASE IN THE SENSITIZATION OF TUMOR CELLSAbandonedAug 10, 11Jul 04, 13[A61K]
2013/0109,629 BLOCKADE OF CCL18 SIGNALING VIA CCR6 AS A THERAPEUTIC OPTION IN FIBROTIC DISEASES AND CANCERAbandonedJun 24, 11May 02, 13[A61K, C07K]
2013/0102,879 Method For Correcting Susceptibility-Induced Image Artifacts In MRI After Prospective Motion CorrectionAbandonedApr 14, 10Apr 25, 13[A61B]
8395385 Simultaneous excitation and acquisition of signal from multiple slices in the RARE sequence (multiplex RARE)ExpiredApr 01, 10Mar 12, 13[G01R, G01V]
2012/0328,686 Pharmaceutical Composition Comprising miRNA-100 And Its Use in the Modulation Of Blood Vessel Growth and Endothelial InflammationAbandonedNov 18, 10Dec 27, 12[C07H, A61K, A61P]
2012/0329,854 Methods and Compounds for the Diagnosis and Treatment for CancerAbandonedAug 03, 10Dec 27, 12[C07H, A61K, G01N, A61P, C07K]
8293494 Tri-demethylation-capable protein complex, method of its preparation and its useExpiredJan 07, 08Oct 23, 12[C12Q, G01N]
2012/0142,784 LYSINE-SPECIFIC DEMETHYLASE 1(LSD1) IS A BIOMARKER FOR BREAST CANCERAbandonedJun 04, 10Jun 07, 12[H01J, A61K, C12Q, G01N, A61P]
2012/0096,568 TRANSGENIC LSD1 ANIMAL MODEL FOR CANCERAbandonedApr 28, 10Apr 19, 12[A61K, C12N, A01K]
8076094 Phosphorylation of histone H3 at threonine 11—a novel epigenetic mark for transcriptional regulationExpiredMay 27, 08Dec 13, 11[G01N]
2011/0275,929 Device and method for measuring contrast agentAbandonedMay 04, 11Nov 10, 11[A61B]
2011/0229,895 METHOD FOR DIAGNOSING POLYCYSTIC KIDNEY DISEASEAbandonedJan 17, 07Sep 22, 11[C12Q, G01N, C07K]
2011/0197,886 RESPIRATORY DEVICE AND METHOD FOR VENTILATING A PATIENTAbandonedApr 13, 05Aug 18, 11[A61M]
7981623 Repressor of skeletal muscle differentiation, nucleic acids coding therefor and the use thereof in diagnosis and therapyExpiredDec 22, 08Jul 19, 11[G01N]
2011/0110,976 RIFT VALLEY FEVER VIRUS-LIKE PARTICLES AND THEIR USE FOR IMMUNIZATION AND AS TEST SYSTEMAbandonedJun 09, 09May 12, 11[A61K, C12Q, C12P, G01N, A61P, C07K]
2011/0045,509 Method For Determining The Type of an Inflammatory-Rheumatic Disease in Synovial FluidAbandonedMar 05, 09Feb 24, 11[G01N, C07K]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.